Global /South Korea /Healthcare /Biotechnology /225220

Genolution Inc.

225220

• KRX: 225220 • Delayed

1,925KRW -1.3%

1.26 USD

As of 13 June 2026, Genolution Inc. has a market cap of $22.87M USD, ranking #36145 globally and #2277 in South Korea. It ranks #3245 in the Healthcare sector, and #631 in the Biotechnology industry.

Global Rank

36145

Country Rank

2277

Sector Rank

3245

Industry Rank

631

Key Stats

Market Cap

$22.87MUSD

34.78B KRW

Enterprise Value

$19.9MUSD

30.37B KRW

Revenue (TTM)

$6.18MUSD

9.4B KRW

EBITDA (TTM)

-$4.11MUSD

-6.28B KRW

Net Income (TTM)

-$7.66MUSD

-11.64B KRW

EBITDA Margin

-67%

Profit Margin

-124%

PS Ratio

3.7

PB Ratio

0.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Ki-Ok Kim open_in_new

Employees

Founded

2006

Website

genolution.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	0.1%	7.1%	-1.7%	-12%	2.7%	-12%	-65%	-78%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	225220 (주)제놀루션 ISIN: KR7225220003 Shares Out.: Shares Outstanding: 18.067M¹ Shares Float: 12.127M² TV: TradingView: KRX: 225220 SA: Stock Analysis: KRX: 225220 YF: Yahoo Finance: 225220.KS GF: Google Finance: KRX: 225220 BA: Barron's: 225220 MS: Morningstar: XKRX: 225220	1,925 KRW	TV: TradingView: KRX: 225220 SA: Stock Analysis: KRX: 225220 YF: Yahoo Finance: 225220.KS GF: Google Finance: KRX: 225220 BA: Barron's: 225220 MS: Morningstar: XKRX: 225220

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Genolution Inc.

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products. Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 196K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 123K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.37B 20.33T KRW 58K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.51B 8.37T KRW 24K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.99B 6.07T KRW 17K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 10K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 798K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 699K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 209K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 185K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 185K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 121K%	-	United States

chevron_leftBack